![Conny Börje Bogentoft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Conny Börje Bogentoft
Direttore/Membro del Consiglio presso
Galenica AB
Profilo
Conny Börje Bogentoft is currently a Director at Galenica AB since 2008.
Prior to this, he served as the Chief Executive Officer at Karolinska Development AB (Private Equity) from 2003 to 2010.
He also held director positions at various firms including Promore Pharma AB, Omnio Healer AB, PharmaSurgics In Sweden AB, Umecrine AB, and Lipidor AB.
Posizioni attive di Conny Börje Bogentoft
| Società | Posizione | Inizio |
|---|---|---|
Galenica AB
 Galenica AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical drugs | Direttore/Membro del Consiglio | 01/01/2008 |
Precedenti posizioni note di Conny Börje Bogentoft
| Società | Posizione | Fine |
|---|---|---|
Omnio Healer AB
 Omnio Healer AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Direttore/Membro del Consiglio | 19/01/2012 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Presidente | 23/08/2010 |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Develops therapeutic peptides for the bioactive would care market | Direttore/Membro del Consiglio | - |
Umecrine AB
 Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Direttore/Membro del Consiglio | - |
| LIPIDOR AB | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
16
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Develops therapeutic peptides for the bioactive would care market | Health Technology |
Omnio Healer AB
Omnio Healer AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Umecrine AB
Umecrine AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pharmaceutical company that develops novel class of drugs to treat neurological disorders | Commercial Services |
Lipidor AB
 Lipidor AB Miscellaneous Commercial ServicesCommercial Services Develops and commercializes lipid-based topical medication products | Commercial Services |
Galenica AB
Galenica AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical drugs | Health Technology |
